TrialOncology reports2017

MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.

Taiki Kijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.